For gene regulation and helpful analysis, abm presents a variety of expression methods for:

1. siRNA: effectively categorical any goal siRNA to knockdown any gene with out the need to design hair-pin loop shRNA constructions, obtainable in lentivirus, AAV and Adenovirus.
2. miRNA: inhibit or over-express any miRNA for analysis of post-transcriptional gene regulation in mammalian methods using our ready-to-use viral vectors and packaged viruses, along with our detection and quantification devices.
3. UTR Reporters: quantitatively analysis a specific miRNA’s regulation of its goal gene using our 3’UTR or 5’UTR platform, all obtainable as a library of premade lentiviral vectors and lentiviruses for any human, mouse or rat gene.

 

Key Choices

• We offer a gaggle of miRNA Inhibitors for knockdown of over 5000 miRNAs from human, mouse, and rat.
• Lentiviral current for integration of genetic supplies into host cells, inflicting protected, long term gene expression.
• Lentivirus has a broad host differ and will infect every dividing and non-dividing cells, allowing gene current to every form of cell varieties.

Background

Non-coding RNAs and significantly microRNAs have been discovered to behave as grasp regulators of most cancers initiation and enchancment. The intention of our analysis was to hunt out and characterize the carry out of nonetheless functionally uncharacterized microRNAs in human breast carcinogenesis.

Methods

In an unbiased methodology, we utilized a longtime model system for breast most cancers (BC) stem cell formation (“mammosphere assay”) to search out out full miRNome alterations in breast carcinogenesis. Medical samples of BC victims had been used to guage the human relevance of the newly acknowledged miRNA candidates. One promising candidate, miR-1287-5p, was additional explored on its impression on a great deal of hallmarks of most cancers. The molecular mode of movement was characterised by full transcriptome analysis, in silico prediction devices, miRNA-interaction assays, pheno-copy assays, and drug sensitivity assays.

hsa-let-7c miRNA Inhibitor
MIH01007	ABM	2 x 5.0 nmol	EUR 176

hsa-let-7d miRNA Inhibitor
MIH01010	ABM	2 x 5.0 nmol	EUR 176

hsa-let-7e miRNA Inhibitor
MIH01013	ABM	2 x 5.0 nmol	EUR 176

hsa-let-7g miRNA Inhibitor
MIH01020	ABM	2 x 5.0 nmol	EUR 176

hsa-let-7i miRNA Inhibitor
MIH01023	ABM	2 x 5.0 nmol	EUR 176

hsa-miR-1 miRNA Inhibitor
MIH01026	ABM	2 x 5.0 nmol	EUR 176

hsa-miR-100 miRNA Inhibitor
MIH01027	ABM	2 x 5.0 nmol	EUR 176

hsa-miR-101 miRNA Inhibitor
MIH01030	ABM	2 x 5.0 nmol	EUR 176

hsa-miR-103 miRNA Inhibitor
MIH01033	ABM	2 x 5.0 nmol	EUR 176

hsa-miR-103b miRNA Inhibitor
MIH01037	ABM	2 x 5.0 nmol	EUR 176

hsa-miR-105 miRNA Inhibitor
MIH01038	ABM	2 x 5.0 nmol	EUR 176

hsa-miR-106a miRNA Inhibitor
MIH01041	ABM	2 x 5.0 nmol	EUR 176

hsa-miR-106b miRNA Inhibitor
MIH01044	ABM	2 x 5.0 nmol	EUR 176

hsa-miR-107 miRNA Inhibitor
MIH01047	ABM	2 x 5.0 nmol	EUR 176

hsa-miR-10a miRNA Inhibitor
MIH01048	ABM	2 x 5.0 nmol	EUR 176

hsa-miR-10b miRNA Inhibitor
MIH01051	ABM	2 x 5.0 nmol	EUR 176

hsa-miR-1178 miRNA Inhibitor
MIH01054	ABM	2 x 5.0 nmol	EUR 176

hsa-miR-1179 miRNA Inhibitor
MIH01057	ABM	2 x 5.0 nmol	EUR 176

hsa-miR-1180 miRNA Inhibitor
MIH01058	ABM	2 x 5.0 nmol	EUR 176

hsa-miR-1181 miRNA Inhibitor
MIH01061	ABM	2 x 5.0 nmol	EUR 176

hsa-miR-1182 miRNA Inhibitor
MIH01062	ABM	2 x 5.0 nmol	EUR 176